The protein FKBP51 is an important regulator of stress hormone receptors and a potential target for the treatment of depression, obesity...

On November 2/3 the 2nd annual retreat of our Cluster4Future PROXIDRUGS took place in Bad Brückenau. We had inspiring presentations and...

From Oct 3rd to Oct 6th 2023 the EMBO-FEBS Lecture Course will give a comprehensive overview of past and current work on proteostasis to...

You would like to learn - which objectives the Hessian clusters and networks pursue? - what activities there are in the...

The associated PROXIDRUGS partner Revvity launched a detection kit for quantifying the expression level of RNA-binding motif protein 39...

Today the PROXIDRUGS consortium met to get started with the conceptualization of the second funding period. It was a fruitful day full of...

Join a continuously expanding research-driven partnership focused on innovative therapies for human diseases. Funded within the first...

The PROXIDRUGS community welcomes Judith Frydman (Stanford University, USA) at Goethe University. Judith Frydman was awarded with the...

Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives...

Together with Brenda Schulman, Director at the Max Planck Institute of Biochemistry in Martinsried, PROXIDRUGS speaker Ivan Đikić will...